In one paragraphArticle in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Oliwia MakarewiczInstitute of Infectious Diseases and Infection Control, Jena University Hospital, Friedrich Schiller University Jena, Am Klinikum 1, 07747 Jena, Germany.ORCID 0000-0002-4404-1862 Tinatini TchatchiashviliInstitute of Infectious Diseases and Infection Control, Jena University Hospital, Friedrich Schiller University Jena, Am Klinikum 1, 07747 Jena, Germany.ORCID 0000-0002-0281-1208 Lisa JasefInstitute of Infectious Diseases and Infection Control, Jena University Hospital, Friedrich Schiller University Jena, Am Klinikum 1, 07747 Jena, Germany.
Mark P G van der LindenUniklinik RWTH Aachen, Institute of Medical Microbiology, Referenzlabor für Streptokokken, Pauwelstraße 30, 52074 Aachen, Germany.ORCID 0000-0002-6574-4313 Sylwia JarzynkaDepartment of Medical Biology, Medical University of Warsaw, Litewska 14/16, 00-575 Warsaw, Poland.ORCID 0000-0002-9269-3494 Kamila StromDepartment of Medical Biology, Medical University of Warsaw, Litewska 14/16, 00-575 Warsaw, Poland.ORCID 0000-0003-4109-0391 Nico UeberschaarMass Spectrometry Platform, Friedrich Schiller University Jena, Humboldtstraße 8, 07743 Jena, Germany.ORCID 0000-0002-4192-490X Gabriela OledzkaDepartment of Medical Biology, Medical University of Warsaw, Litewska 14/16, 00-575 Warsaw, Poland.ORCID 0000-0001-7090-6156 Mathias W PletzInstitute of Infectious Diseases and Infection Control, Jena University Hospital, Friedrich Schiller University Jena, Am Klinikum 1, 07747 Jena, Germany.ORCID 0000-0001-8157-2753 Funding
This work was supported by grants from the German Ministry of Education and Research (BMBF) (Grant Nos. 13N15467 and 13N15720), the 'Excellence initiative - research university' programme (IDUB), implemented by the Polish Ministry of Science and Higher Ed Grant Nos. 13N15467 and 13N15720, Project No. NZI/2/UW.II.14/N/21/21, Projekt-Nr. 433052568,
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Anti-Bacterial AgentsMilk, HumanOligosaccharidesStreptococcus pneumoniaeFemaleHumansMicrobial Sensitivity TestsPneumococcal InfectionsAnti-Bacterial AgentsOligosaccharidesadjunctsantimicrobialsbacteriakineticpneumoniavaccine
Identifiers
PMID41226817
PMCPMC12609556
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390